8 medicines held by Substipharm on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Efient 10 mg Film-coated tablet EU/1/08/503/8-14 |
Prasugrel hydrochloride | Substipharm | — |
| Efient 5 mg Film-coated tablet EU/1/08/503/1-7 |
Prasugrel hydrochloride | Substipharm | — |
| Evista 60 mg film coated tablets EU/1/98/073/001 |
Raloxifene | Substipharm | — |
| Evista 60 mg film coated tablets EU/1/98/073/002 |
Raloxifene | Substipharm | — |
| Evista 60 mg film coated tablets EU/1/98/073/003 |
Raloxifene | Substipharm | — |
| Evista 60 mg film coated tablets EU/1/98/073/004 |
Raloxifene | Substipharm | — |
| Iverscab 3 mg tablets PA1677/008/001 |
Ivermectin | Substipharm | Not marketed |
| Mycostatin 100,000 units/ml Oral Suspension (Ready Mixed) PA1677/007/007 |
Nystatin | Substipharm | Marketed |
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.